Joseph Cheung, MD
Sleep Medicine · Jacksonville, FLNPI 1811218480
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,004 of the $12,412 with a category attached, or 80.6%. Jazz Pharmaceuticals Inc. accounts for 96.4% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $11,951, more than ten times the $21 reported in 2021.
Across 26 payments — averaging $477.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$12K
- Avadel CNS Pharmaceuticals, LLC$200
- Inspire Medical Systems, Inc.$134
- Harmony Biosciences LLC$66
- Axsome Therapeutics, Inc.$27
- Fisher & Paykel Healthcare Inc$21
Across 1 payment — averaging $82.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dexcom, Inc.$82
What the payments were for
- Consulting fees$3503%
- Speaking & faculty fees$10,00481%
- Travel & lodging$9868%
- Food & beverage$9378%
- Education$1351%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 19 | $11,965 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $200 |
| Inspire Medical Systems, Inc. | 2 | $134 |
| Harmony Biosciences LLC | 2 | $66 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Fisher & Paykel Healthcare Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,412 in reported general payments places this provider in the 80th percentile of 77 sleep medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 53 | $1,614 |
| Armodafinil | 17 | $610 |
| Gabapentin | 14 | $125 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Jacksonville
- Brendon ColacoJacksonville$14K
- Daniel ThielemannJacksonville$2K
- Nura FesticJacksonville$2K
- Gonzalo Labarca TruciosJacksonville$2K
- Loan leJacksonville$764
- Brynn DredlaJacksonville$708
- Jeremy McConnellBradenton$615K
- Edward MezerhaneMiami$537K
- Shane DrahosWinter Garden$317K
- Kunal AgarwalSarasota$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.